(E)-N-{3-(8-Chloro-11H-10-oxa-1-aza- dibenzo[a,d]cyclohepten-5-ylidene)-propyl]-phenyl} -methanesulfonamide as a GLUCOCORTICOID RECEPTOR MODULATOR AND METHODS OF USE
申请人:ELI LILLY AND COMPANY
公开号:EP2043646B1
公开(公告)日:2012-05-16
[EN] GLUCOCORTICOID RECEPTOR MODULATOR AND METHODS OF USE<br/>[FR] MODULATEUR DU RÉCEPTEUR DES GLUCOCORTICOÏDES ET PROCÉDÉS D'UTILISATION
申请人:LILLY CO ELI
公开号:WO2008008882A2
公开(公告)日:2008-01-17
[EN] The present invention provides Compound (I): Compound (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with one or more pharmaceutically acceptable carriers, excipients, or diluents; and methods for the treatment of inflammatory and immune disorders comprising administering to a patient in need thereof an effective amount of Compound (I) or a pharmaceutically acceptable salt thereof. [FR] La présente invention concerne un composé (I) : Composé (I) ou un de ses sels pharmaceutiquement acceptable ; des compositions pharmaceutiques comprenant le composé (I) combiné à un ou plusieurs véhicules, excipients or diluants pharmaceutiquement acceptables ; et des procédés de traitement de troubles inflammatoires ou immunitaires comprenant l'administration à un patient qui en a besoin d'une quantité efficace de composé (I) ou d'un de ses sels pharmaceutiquement acceptable.
GLUCOCORTICOID RECEPTOR MODULATOR AND METHODS OF USE
申请人:Carson Matthew William
公开号:US20100069425A1
公开(公告)日:2010-03-18
The present invention provides Compound (I): Compound (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with one or more pharmaceutically acceptable carriers, excipients, or diluents; and methods for the treatment of inflammatory and immune disorders comprising administering to a patient in need thereof an effective amount of Compound (I) or a pharmaceutically acceptable salt thereof.